Cargando…

Defining Pathological Activities of ALK in Neuroblastoma, a Neural Crest-Derived Cancer

Neuroblastoma is a common extracranial solid tumour of childhood, responsible for 15% of cancer-related deaths in children. Prognoses vary from spontaneous remission to aggressive disease with extensive metastases, where treatment is challenging. Tumours are thought to arise from sympathoadrenal pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wulf, Anna M., Moreno, Marcela M., Paka, Chloé, Rampasekova, Alexandra, Liu, Karen J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584162/ https://www.ncbi.nlm.nih.gov/pubmed/34769149 http://dx.doi.org/10.3390/ijms222111718

Ejemplares similares

ALK and GSK3: Shared Features of Neuroblastoma and Neural Crest Cells
por: Gonzalez Malagon, Sandra G, et al.
Publicado: (2018)

Neuroblastoma—A Neural Crest Derived Embryonal Malignancy
por: Johnsen, John Inge, et al.
Publicado: (2019)

MYCN induces neuroblastoma in primary neural crest cells
por: Olsen, R R, et al.
Publicado: (2017)

Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia
por: Vivancos Stalin, Lucie, et al.
Publicado: (2019)

ALKALs are in vivo ligands for ALK family receptor tyrosine kinases in the neural crest and derived cells
por: Fadeev, Andrey, et al.
Publicado: (2018)

Defective ALK5 signaling in the neural crest leads to increased postmigratory neural crest cell apoptosis and severe outflow tract defects
por: Wang, Jikui, et al.
Publicado: (2006)

Hijacking of Embryonic Programs by Neural Crest-Derived Neuroblastoma: From Physiological Migration to Metastatic Dissemination
por: Delloye-Bourgeois, Céline, et al.
Publicado: (2019)

Environmental cues from neural crest derivatives act as metastatic triggers in an embryonic neuroblastoma model
por: Ben Amar, Dounia, et al.
Publicado: (2022)

Differential requirement of bone morphogenetic protein receptors Ia (ALK3) and Ib (ALK6) in early embryonic patterning and neural crest development
por: Schille, Carolin, et al.
Publicado: (2016)

Neural crest derived progenitor cells contribute to tumor stroma and aggressiveness in stage 4/M neuroblastoma
por: Linares-Clemente, Pedro, et al.
Publicado: (2017)

Neuropilins define distinct populations of neural crest cells
por: Lumb, Rachael, et al.
Publicado: (2014)

Injection of human neuroblastoma cells into neural crest streams in live zebrafish embryos
por: Ibarra, Beatriz A., et al.
Publicado: (2022)

ALK in Neuroblastoma: Biological and Therapeutic Implications
por: Trigg, Ricky M., et al.
Publicado: (2018)

Wild-type ALK and activating ALK-R1275Q and ALK-F1174L mutations upregulate Myc and initiate tumor formation in murine neural crest progenitor cells
por: Montavon, Gisèle, et al.
Publicado: (2014)

Immunoassays for the quantification of ALK and phosphorylated ALK support the evaluation of on‐target ALK inhibitors in neuroblastoma
por: Tucker, Elizabeth R., et al.
Publicado: (2017)

MYCN and mutationally activated ALK synergise in neuroblastoma
Publicado: (2012)

Disorders of neural crest derivates in oncoradiological practice
por: Papp, Tamas, et al.
Publicado: (2019)

Loss of ALK hotspot mutations in relapsed neuroblastoma
por: Allinson, Lisa M., et al.
Publicado: (2022)

Neuroendocrine Cells of the Prostate Derive from the Neural Crest
por: Szczyrba, Jaroslaw, et al.
Publicado: (2017)

Neural network learning defines glioblastoma features to be of neural crest perivascular or radial glia lineages
por: Hu, Yizhou, et al.
Publicado: (2022)

Leader Cells Define Directionality of Trunk, but Not Cranial, Neural Crest Cell Migration
por: Richardson, Jo, et al.
Publicado: (2016)

Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib
por: Guan, Jikui, et al.
Publicado: (2018)

Targeting MYCN and ALK in resistant and relapsing neuroblastoma
por: Tucker, Elizabeth R, et al.
Publicado: (2019)

Genomic ALK alterations in primary and relapsed neuroblastoma
por: Rosswog, Carolina, et al.
Publicado: (2023)

Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
por: Tucker, Elizabeth R., et al.
Publicado: (2023)

Dissection, Culture and Analysis of Primary Cranial Neural Crest Cells from Mouse for the Study of Neural Crest Cell Delamination and Migration
por: Gonzalez Malagon, Sandra Guadalupe, et al.
Publicado: (2019)

Regeneration of neural crest derivatives in the Xenopus tadpole tail
por: Lin, Gufa, et al.
Publicado: (2007)

A molecular atlas of the developing ectoderm defines neural, neural crest, placode, and nonneural progenitor identity in vertebrates
por: Plouhinec, Jean-Louis, et al.
Publicado: (2017)

Pathological ASXL1 Mutations and Protein Variants Impair Neural Crest Development
por: Matheus, Friederike, et al.
Publicado: (2019)

ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation
por: Borenäs, Marcus, et al.
Publicado: (2021)

Advillin Is Expressed in All Adult Neural Crest-Derived Neurons
por: Hunter, Diana V., et al.
Publicado: (2018)

Activating mutations in ALK provide a therapeutic target in neuroblastoma
por: George, Rani E., et al.
Publicado: (2008)

Alectinib, an Anaplastic Lymphoma Kinase Inhibitor, Abolishes ALK Activity and Growth in ALK-Positive Neuroblastoma Cells
por: Alam, Muhammad Wasi, et al.
Publicado: (2019)

Anaplastic lymphoma kinase (ALK) inhibitor response in neuroblastoma is highly correlated with ALK mutation status, ALK mRNA and protein levels
por: Duijkers, Floor A. M., et al.
Publicado: (2011)

Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells
por: Acosta, Sandra, et al.
Publicado: (2009)

Exploring Shared Susceptibility between Two Neural Crest Cells Originating Conditions: Neuroblastoma and Congenital Heart Disease
por: Testori, Alessandro, et al.
Publicado: (2019)

Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma
por: Pacenta, Holly L, et al.
Publicado: (2018)

5′ ALK Amplification in Neuroblastoma: A Case Report
por: Akhavanfard, Sara, et al.
Publicado: (2021)

Identification of ALK Mutation in Neuroblastoma on the Point of Molecular Heterogeneity
por: Aktaş, Tekincan Çağrı, et al.
Publicado: (2023)

CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours
por: Vega, Francisco M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e73ve1oek1oa5armniad71910f